Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer

NCT03792932 | Unknown

• 1 other identifier: CSPAC-2
• Study Type: interventional
• Target: 306
• Locations: 1 country
• Sites: 11

Brief Summary

Open distal pancreatectomy (ODP) has been commonly employed for the treatment of a variety of cancers in body and tail of pancreas. Although many general surgical procedures have been increasingly performed laparoscopically or with laparoscopic assistance, until the current decade, laparoscopic pancreatic surgery had not been performed for its complicated anatomy. But laparoscopic distal pancreatectomy (LDP) has been widely accepted as a standard treatment for body and tail pancreatic cancer because there is no anastomosis in it, and LDP has gradually become the first choice for these cancers in clinical work. Although there are several studies about the comparison between LDP and ODP, most are retrospective and there is no agreement in surgical margin, lymph node numbers and prognosis to identify the oncological differences between the two surgical approaches. The investigators' pilot study showed that patients with body and tail pancreatic cancer underwent LDP had a better prognosis compared with the ones undergoing ODP, with no statistics differences in postoperative complications and mortality. This perspective RCT study is performed to confirm whether LDP would improve the prognosis for patients with body and tail pancreatic cancer compared with ODP.

Conditions

Pancreatic Cancer; Surgery; Laparoscopy

Outcome Measures

Primary Outcomes (1)

• Recurrence Free Survival

  RFS

  2 years

Secondary Outcomes (3)

• Overall Survival

  2 years

• R0 resection rate

  2 years

• Detected lymph node number

  2 years

Study Arms (2)

Laparoscopic distal pancreatectomy

ACTIVE COMPARATOR

Procedure: Laparoscopic distal pancreatectomy

Open distal pancreatectomy

ACTIVE COMPARATOR

Procedure: Open distal pancreatectomy

Interventions

Laparoscopic distal pancreatectomy PROCEDURE

Laparoscopic distal pancreatectomy includes distal pancreatectomy, splenectomy, and regional lymph nodes resection for pancreatic cancer at the body and tail. Regional lymph nodes includes group 8, 10, 11, 18, 7, 9, 14, 15, according to the 2003 edition of lymph nodes group system defined by Japan Pancreas Society (JPS).

Laparoscopic distal pancreatectomy

Open distal pancreatectomy PROCEDURE

Open distal pancreatectomy includes distal pancreatectomy, splenectomy, and regional lymph nodes resection for pancreatic cancer at the body and tail. Regional lymph nodes includes group 8, 10, 11, 18, 7, 9, 14, 15, according to the 2003 edition of lymph nodes group system defined by Japan Pancreas Society (JPS).

Open distal pancreatectomy

Eligibility Criteria

• Age: 19 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age ≥ 19 years and ≤ 80 years, no gender limitation
• Resectable body and tail pancreatic cancer (refer to NCCN 2018)
• Eastern Cooperative Oncology Group (ECOG) performance status 0-1
• Tumor locates at the body and tail of the pancreas without distant metastasis
• No celiac trunk and superior mesenteric artery invasion
• No operation contraindication, fit for laparoscopic surgery
• The expected survival after surgery ≥ 3 months
• Patients who are willing and able to comply with the study procedure
• Signed informed content obtained prior to treatment

You may not qualify if:

• Locally advanced unresectable body and tail pancreatic cancer
• Multi-organ and vascular resection needed
• Patients undergoing total pancreatectomy
• Benign tumor at the body and tail of the pancreas or pancreatic cancer at the head of the pancreas
• Distant metastasis or ascites detected by imaging
• Severe important organ function impairment (heart, liver, kidney)
• Patients who are with other primary malignancy or haematological disorders
• Pregnant or nursing women
• Patients who have received chemotherapy, radiotherapy and interventional therapy before the pancreatectomy
• Patients who have participated in other clinical trials for pancreatic cancer treatment within 3 months

Sponsors & Collaborators

• Fudan University: lead

Study Sites (11)

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)

Hefei, Anhui, China

RECRUITING

Department of Hepatobiliary and Pancreatic Surgery, The Second Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

RECRUITING

Department of Hepatopancreatobiliary Surgery, Second Affiliated Hospital of Harbin Medical University,

Harbin, Heilongjiang, China

RECRUITING

Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China

RECRUITING

Department of Hepato-Pancreato-Biliary Surgery, The Affiliated Hospital of Xuzhou Medical University

Xuzhou, Jiangsu, China

RECRUITING

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Shanghai Pancreatic Cancer Institute; Pancreatic Cancer Institute, Fudan University. Shanghai, China

Shanghai, Shanghai Municipality, 200032, China

RECRUITING

Shanghai Changzheng Hospital

Shanghai, Shanghai Municipality, China

RECRUITING

West China Hospital

Chengdu, Sichuan, 610041, China

RECRUITING

Department of Gastroenterology and Pancreatic Surgery, Zhejiang Provincial People's Hospital

Hanzhou, Zhejiang, China

RECRUITING

Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University

Harbin, China

RECRUITING

Department of Biliopancreatic Surgery, Huadong Hospital, Fudan University

Shanghai, China

RECRUITING

Related Publications (5)

• Ricci C, Casadei R, Taffurelli G, Toscano F, Pacilio CA, Bogoni S, D'Ambra M, Pagano N, Di Marco MC, Minni F. Laparoscopic versus open distal pancreatectomy for ductal adenocarcinoma: a systematic review and meta-analysis. J Gastrointest Surg. 2015 Apr;19(4):770-81. doi: 10.1007/s11605-014-2721-z. Epub 2015 Jan 6.

  PMID: 25560180 BACKGROUND

• van Hilst J, de Rooij T, Klompmaker S, Rawashdeh M, Aleotti F, Al-Sarireh B, Alseidi A, Ateeb Z, Balzano G, Berrevoet F, Bjornsson B, Boggi U, Busch OR, Butturini G, Casadei R, Del Chiaro M, Chikhladze S, Cipriani F, van Dam R, Damoli I, van Dieren S, Dokmak S, Edwin B, van Eijck C, Fabre JM, Falconi M, Farges O, Fernandez-Cruz L, Forgione A, Frigerio I, Fuks D, Gavazzi F, Gayet B, Giardino A, Groot Koerkamp B, Hackert T, Hassenpflug M, Kabir I, Keck T, Khatkov I, Kusar M, Lombardo C, Marchegiani G, Marshall R, Menon KV, Montorsi M, Orville M, de Pastena M, Pietrabissa A, Poves I, Primrose J, Pugliese R, Ricci C, Roberts K, Rosok B, Sahakyan MA, Sanchez-Cabus S, Sandstrom P, Scovel L, Solaini L, Soonawalla Z, Souche FR, Sutcliffe RP, Tiberio GA, Tomazic A, Troisi R, Wellner U, White S, Wittel UA, Zerbi A, Bassi C, Besselink MG, Abu Hilal M; European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS). Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched Study. Ann Surg. 2019 Jan;269(1):10-17. doi: 10.1097/SLA.0000000000002561.

  PMID: 29099399 BACKGROUND

• Sulpice L, Farges O, Goutte N, Bendersky N, Dokmak S, Sauvanet A, Delpero JR; ACHBT French Pancreatectomy Study Group. Laparoscopic Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: Time for a Randomized Controlled Trial? Results of an All-inclusive National Observational Study. Ann Surg. 2015 Nov;262(5):868-73; discussion 873-4. doi: 10.1097/SLA.0000000000001479.

  PMID: 26583678 BACKGROUND

• Shin SH, Kim SC, Song KB, Hwang DW, Lee JH, Lee D, Lee JW, Jun E, Park KM, Lee YJ. A comparative study of laparoscopic vs. open distal pancreatectomy for left-sided ductal adenocarcinoma: a propensity score-matched analysis. J Am Coll Surg. 2015 Feb;220(2):177-85. doi: 10.1016/j.jamcollsurg.2014.10.014. Epub 2014 Oct 31.

  PMID: 25529901 BACKGROUND

• Venkat R, Edil BH, Schulick RD, Lidor AO, Makary MA, Wolfgang CL. Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis. Ann Surg. 2012 Jun;255(6):1048-59. doi: 10.1097/SLA.0b013e318251ee09.

  PMID: 22511003 BACKGROUND

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Endocrine Gland Neoplasms; Digestive System Diseases; Pancreatic Diseases; Endocrine System Diseases

Central Study Contacts

Xianjun Yu, M.D., Ph.D.

CONTACT

+86-21-64175590; yuxianjun@fudanpci.org

He Cheng, M.D., Ph.D.

CONTACT

+86-21-64175590; chenghe@fudanpci.org

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Chair of Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University

Study Record Dates

• First Submitted: December 27, 2018
• First Posted: January 4, 2019
• Study Start: February 2, 2019
• Primary Completion: January 31, 2023
• Study Completion: January 31, 2023
• Last Updated: June 22, 2022

Record last verified: 2022-06

Data Sharing

• IPD Sharing: Will not share

Locations

CN (11)